AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡²

Erythromycin Estolate in Zambia

1 product registered with ZAMRA β€” 1 active

Brand / ProductReg. No.HolderStatusExpires
Galthrox 125 oral suspension
Suspension for Oral Use
200/026GALPHA LABORATORIES LIMITEDactive2 Jun 2029

Erythromycin Estolate β€” ZAMRA Registration Details

ZAMRA (Zambia) has 1 registered product containing Erythromycin Estolate, of which 1 is currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.

Track Erythromycin Estolate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Erythromycin Estolate β€” Zambia (ZAMRA) | AfricaRegulatory